de Tute RM, Cook G, Cairns DA, Brown JM, et al. Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial. Bone Marrow Transplant 2024 Jan 9. doi: 10.1038/s41409-023-02164.
PMID: 38195983